Cutler Group LP Citius Pharmaceuticals, Inc. Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 01, 2023	SELL	$0.78 - $1.42 $173,004 - $314,956	-221,800 Reduced 99.78%	500 $0
Q4 2022 Feb 07, 2023	SELL	$0.79 - $1.28 $1,975 - $3,200	-2,500 Reduced 1.11%	222,300 $5,000
Q3 2022 Oct 25, 2022	SELL	$0.14 - $1.33 $42 - $399	-300 Reduced 0.13%	224,800 $28,000
Q2 2022 Aug 04, 2022	SELL	$0.88 - $1.87 $58,256 - $123,794	-66,200 Reduced 22.73%	225,100 $17,000
Q1 2022 Apr 14, 2022	BUY	$1.38 - $1.89 $264,270 - $361,935	191,500 Added 191.88%	291,300 $112,000
Q4 2021 Jan 18, 2022	SELL	$1.51 - $2.2 $101,774 - $148,280	-67,400 Reduced 40.31%	99,800 $23,000
Q3 2021 Oct 26, 2021	BUY	$1.74 - $2.6 $244,644 - $365,560	140,600 Added 528.57%	167,200 $45,000
Q2 2021 Jul 19, 2021	BUY	$1.51 - $4.23 $40,166 - $112,518	26,600 New	26,600 $18,000

23.7M

83.1K

32.1K

Ticker CTXR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 146,130,000
Market Cap $378M
Description
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.